Pfizer vaccination commences in Maldives via appointment

Covid-19 vaccine
Pfizer says its experimental COVID-19 vaccine is 95% effective | Photo: AFP

Malé, Maldives – Health Protection Agency (HPA) of Maldives started administering Pfizer vaccine to registered individuals via appointment basis in Malé City yesterday, April 11, 2021.

The vaccine is currently being administered at ADK Hospital in Malé and Hulhumalé Hospital.

Pfizer vaccine in the Maldives will be administered to minors of ages 16 and 17 with long-term illnesses, elderly patients above 60 currently seeking treatment for a chronic health condition and immunocompromised adults between 18 to 60.

People considered as high risk can register for Pfizer vaccine, including those who have performed an organ transplant, people who do dialysis on a regular basis, people who are doing chemotherapy or radiotherapy, people taking medicines which lower their immunity and those who take steroids on a long term basis which is more than 10mg per day for over a month.

In addition to these categories of people, people with diabetes, thalassemia major, people with sickle cell anemia, people with Down syndrome, people with lung disease such as cystic fibrosis and bronchiectasis and people with heart issues at birth would also be considered for the administration of Pfizer vaccine.

HPA had previously advised people who fall under these categories to get registered through this link.

Pfizer vaccine will be administered so that two doses will be administered with the 5,850 doses which the country had received. Pfizer BioNTech COVID-19 vaccine was initially developed by the German company BioNTech and manufactured by American company Pfizer uses a new mRNA technology. It has been shown to be 95% effective in large-scale clinical trials.